LORAZEPAM
TABLETS 0.5 mg 1000s
NDC: 00591-0240-10
*Compare to: AtivanŽ, a registered trademark of Wyeth-Ayerst
*Brand
names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.
LORAZEPAM
TABLETS 1 mg 1000s
NDC: 00591-0241-10
*Compare to: AtivanŽ, a registered trademark of Wyeth-Ayerst
*Brand
names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.
LORAZEPAM
TABLETS 2 mg 1000s
NDC: 00591-0242-10
*Compare to: AtivanŽ, a registered trademark of Wyeth-Ayerst
*Brand
names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.
LORAZEPAM
2mg/mL INJ CIV 10 x 10mL
NDC: 00591-3365-70
*Compare to: AtivanŽ Injection, a registered trademark of Baxter Anesthes
*Brand
names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.
Lorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
To assure the safe and effective use of lorazepam, patients should be informed that, since benzodiazepines may produce psychological and physical dependence, it is advisable that they consult with their physician before either increasing the dose or abruptly discontinuing this drug.